Hikma Pharmaceutical reported $1.01B in Current Liabilities for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Artemis Alpha ATS:LN GBP 5.37M 25K
AstraZeneca AZN:LN USD 24.85B 3.04B
Bayer BAYN:GR EUR 33.17B 471M
Fresenius FRE:GR EUR 14.86B 562M
Fresenius Medical Care FMS:US EUR 6.36B 519.16M
Galapagos GLPG:NA EUR 532.21M 18.52M
Genmab GEN:DC DKK 2.99B 1.04B
GlaxoSmithKline GSK:LN GBP 22.81B 1.86B
Hikma Pharmaceutical HIK:LN USD 1.01B 6M
Lonza Group LONN:SW CHF 3.08B 454M
Merck MRK:GR EUR 9.41B 306M
Orion ORNBV:FH EUR 252.1M 16.2M
Recordati REC:IM EUR 778.04M 73.16M
Roche Holding ROG:VX 27.41B 11.01B